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TRIP6, a member of the ZYXIN-family of LIM domain proteins, is a focal adhesion compo-
nent. Trip6 deletion in the mouse, reported here, reveals a function in the brain: ependymal
and choroid plexus epithelial cells are carrying, unexpectedly, fewer and shorter cilia, are
poorly differentiated, and the mice develop hydrocephalus. TRIP6 carries numerous protein
interaction domains and its functions require homodimerization. Indeed, TRIP6 disruption
in vitro (in a choroid plexus epithelial cell line), via RNAi or inhibition of its homodimerization,
confirms its function in ciliogenesis. Using super-resolution microscopy, we demonstrate
TRIP6 localization at the pericentriolar material and along the ciliary axoneme. The
requirement for homodimerization which doubles its interaction sites, its punctate localiza-
tion along the axoneme, and its co-localization with other cilia components suggest a scaf-
fold/co-transporter function for TRIP6 in cilia. Thus, this work uncovers an essential role of a
LIM-domain protein assembly factor in mammalian ciliogenesis.
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Cellular interactions, via adhesion between cells or betweencells and extracellular matrix, are hallmarks of multi-cellular organisms, and are formed by multiprotein com-
plexes at cellular membranes. Their nature is transient in that
adhesions are disassembled and reformed during diverse pro-
cesses such as cellular migration, cell division, and tumorigenic
transformation. Communication of neighboring cells, also of
different cell types, is also mediated by specialized cellular
interaction complexes, for example gap junctions. Development
and function of the brain are prime examples of such cell–cell
communications1, from adherens junctions2,3 and gap junctions
to polarity regulation, actin-mediated motility4, and cell–matrix
interactions5.
The formation of multiprotein complexes, including those
involved in adhesions, often requires assembly factors. A family
of scaffold proteins, carrying several protein interaction domains,
serves as platform for protein–protein interactions: the seven-
member ZYXIN LIM domain family6 including ZYXIN, lipoma-
preferred partner LPP, AJUBA, WNT interacting protein WTIP,
LIMD1, MIGFILIN, and thyroid hormone receptor interacting
protein (TRIP6). Most of these proteins localize at focal adhesions
and adherens junctions, compatible with their reported role in the
assembly of adhesion complexes (as first described to be localized
in cell–matrix adhesions by Beckerle7). Their interaction partners
and the cellular functions of these complexes, from actin orga-
nization/cell migration8–10 through tension sensing11–13 to signal
transduction14,15, have been elaborated in numerous cell culture
experiments. The ZYXIN family members show significant
structural and functional similarities6, and exhibit widely similar
tissue specific expression pattern. Indeed, most of them seem to
fully substitute for each other, as indicated by the viability and—
by and large—normal adult life of mice with deletion of the genes
for ZYXIN16, LPP17, AJUBA18, LIMD119, and MIGFILIN20.
In contrast, in embryonic and early postnatal brain only two
members of the ZYXIN family—ajuba and trip6—are expressed,
and in a non-overlapping spatio-temporal pattern. Ajuba
expressing cells were observed in early embryogenesis (embryonic
days E10 to E13) and postnatally (mouse genome informatics
atlas, ref. 21). Trip6 was detected from E14.5 to early postnatal
days with its expression restricted to the SOX2 positive cells of the
ventricles22, and were reported to be expressed, also transiently,
in the embryonic hippocampus, in the medial habenular nucleus,
in the ventral posterior complex and in the thalamus23. In the
adult mouse, single cell RNA profiles from the ventricular zone
(VZ) identified ependymal cells expressing trip6, but also zyxin
and ajuba24. Such analyses have not yet been performed for the
embryonic VZ.
Here, we show that TRIP6 expression in the brain is spanning
the embryonic (E14.5) to early postnatal period. This brain-
restricted and exclusive expression pattern, solely of TRIP6
among all ZYXIN family proteins, encouraged us to delete the
gene in the mouse. While the mice were viable—similarly to mice
with deletion of genes encoding the other ZYXIN family mem-
bers—we observed a major phenotype: development of an
obstructive hydrocephalus. Investigation into the underlying
etiology led us to the discovery of an unexpected function of
TRIP6 in brain ciliogenesis.
Results
TRIP6 expression in the brain. We confirmed trip6 expression
in the murine brain by radioactive in situ hybridization (ISH)
(Fig. 1a). Widespread and intense trip6 hybridization signals were
observed in the extracranial somatic tissues (for whole skull
sections see Supplementary Fig. 1a, b). In the embryonic central
nervous system (CNS) however, trip6 expression was highly
restricted and limited to areas bordering the ventricles (Fig. 1a,
E14.5–E18.5, sagittal sections), in agreement with published
data22. A similar trip6 expression pattern persisted after birth
(Fig. 1a, postnatal days P0–P6, coronal sections), albeit at reduced
expression level, and was undetectable by ISH beyond P10. Trip6
mRNA expression was also detected in choroid plexus, e.g., at
E14.5, E18.5, P0, and P3 (Fig. 1a, arrows). Immunostaining of the
protein confirmed the ISH data and identified the exact region
and cell type expressing TRIP6: a thin layer of cells bordering the
ventricles in the VZ—likely ependymal cells—and epithelial cells
in the choroid plexus anlage, both during embryogenesis (Sup-
plementary Fig. 1c) and postnatally (Fig. 1b).
As expected for a member of the ZYXIN family, TRIP6 co-
localized with β-catenin (Fig. 1b, c and Supplementary Fig. 1c),
ZO1 (Fig. 1c) and N-cadherin (Supplementary Fig. 1c), marking
predominantly the cellular membranes of both ependymal cells
and choroid plexus epithelium. Oblique sections through the
embryonic VZ displayed the net-like structure of the cell
adhesions co-labeled by anti-β-catenin, N-cadherin, and TRIP6
antibodies (Supplementary Fig. 1c). Absence of TRIP6 did not
alter the β-catenin and ZO1 localization (Supplementary Fig. 1d).
Thus, TRIP6 is localized in cellular adhesion complexes, along the
ventricle and in the choroid plexus epithelium.
Trip6 gene deletion in the mouse results in formation of a
hydrocephalus. The generation of knock-out (trip6−/−) mice by
standard technology is outlined in Supplementary Fig. 2. Deletion
of trip6 was confirmed at mRNA level, in choroid plexus, via RT-
qPCR (Supplementary Fig. 2d) and at protein level, in several
organs, via immunoblotting (Supplementary Fig. 2e). The trip6−/−
mice were viable through birth, but a large fraction (44%) in the
C57BL/6J background developed a severe phenotype: hydro-
cephalus (Fig. 2a, b). Haematoxilin-Eosin (H&E) stained brain
tissue revealed significant extension of the lateral ventricles (LV)
in these animals (Fig. 2c). In the fraction of trip6−/− mice escaping
the formation of hydrocephalus, as well as in heterozygotes, the
overall brain morphology was not altered.
High resolution magnetic resonance imaging (MRI) showed
that the LVs were significantly enlarged, whereas no ventriculo-
megaly was detected in the 4th ventricle (Fig. 2d, e). In serial
sagittal and horizontal MRI sections, as well as in maximum
intensity projection (MIP) reconstructions of P21 brains the 3rd
ventricle was in part concealed by the large LV expansion
(Fig. 2d, e and Supplementary Movies 1 and 2). From histological
sections at earlier postnatal days the 3rd ventricle appeared
unaffected (see also below). LV enlargement was first detected at
P1 and maximal extension was reached at P24. This phenotype
speaks for a cerebrospinal fluid (CSF) circulation block in the
foramen of Monro (upstream of the 3rd ventricle) and/or in the
aqueduct of Sylvius, between 3rd and 4th ventricle (reviewed in
ref. 25)—suggesting the existence of an obstructive hydrocephalus.
A small cohort of 22 trip6−/− mice, that had not developed a
hydrocephalus perinatally, were followed for up to 400 days. They
did not form a hydrocephalus later during the observation time,
and their life span did not appear to be shortened in comparison
to trip6+/+.
As congenital hydrocephalus is often accompanied by
delamination of ependymal cells from the dorsal wall of the
aqueduct, with fusion of the ventral and dorsal walls and
consequently aqueduct obliteration26,27, we focused on analysis of
the ependymal cell layer.
Defective ependymal cells in trip6−/− brain. The ventricles of
early postnatal control (trip6+/+) brain (Fig. 3a) are lined by
a single layer of multiciliated cuboidal-to-columnar epithelial
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-26057-6
2 NATURE COMMUNICATIONS |         (2021) 12:5887 | https://doi.org/10.1038/s41467-021-26057-6 | www.nature.com/naturecommunications
cells—the ependymal cells—comprising the ependyma. The
ependymal layer is interspersed with basal cells some of which are
stem cells (Fig. 3a, arrowheads), providing a neurogenic niche28.
Analysis of trip6−/− brain sections (Fig. 3a) revealed a poorly
differentiated epithelial layer comprising atrophic ependymal cells
that exhibit “endothelial” aspects (i.e., flattened cell morphology
and reduced cytoplasm, as indicated by high nuclear/cytoplasmic
ratio) as well as aberrant ciliation demonstrated by defects in cilia
number and length (see below). Furthermore, only few basal cells
were observed (Fig. 3a), suggestive of defective cell renewal, or
reflecting an early cause of poor ependymal differentiation.
Examples of trip6−/− ependymal layers are shown in Fig. 3c
indicating different degrees of poor differentiation.
Immunofluorescence labeling, using anti-S100β, confirmed the
defective differentiation of ependymal cells in trip6−/− brain
(Fig. 4 and Supplementary Figs. 3 and 4a; ependymal cells
indicated by arrows). Note that S100β is expressed not exclusively
in ependymal cells, but also in some glia cells (Fig. 4 and
Supplementary Fig. 3, arrowheads; Supplementary Fig. 4a, stars)
in agreement with previous reports29. In addition to this defective
morphology, elimination of S100β-expressing cells from the VZ
was occasionally observed (Supplementary Figs. 3 and 4).





















































































Fig. 1 Expression of trip6 in embryonic and postnatal brain. a mRNA expression in trip6+/+ mouse brain sections by in situ hybridization (ISH) depicting
embryo sagittal sections (E14.5–E18.5) and postnatal coronal sections (P0–P6). Pall pallium, M midbrain, Tel telencephalic vesicle, H hindbrain, ChP
choroid plexus, Cb cerebellum, CTX cerebral cortex, CPu Caudate Putamen, aca anterior commissure, Pit pituitary, LV lateral ventricle, 3V third ventricle,
Hip hippocampal formation. Choroid plexus locations within the lumen of the ventricles are indicated by arrows. Control sense ISH is shown in
Supplementary Fig. 1a, b. Immunofluorescence labeling of TRIP6 in ependymal cells lining the 4th ventricle (b) and choroid plexus epithelium (c)
demonstrates its co-localization with β-catenin (arrow) and ZO1 (arrowhead). Nuclei were stained with DAPI. The marked areas are magnified in the
insets. Ages are indicated in the figure. For number of mice analyzed, please see “Methods” section. Asterisk (*) indicates the autofluorescence of the
choroid plexus vasculature. Scale bars: 1 mm (a), 50 μm and 250 μm (b and magnified images, respectively), 10 μm (c).
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The “endothelial” appearance of the ependymal layer is
unlikely to be caused by the hydrocephalic pressure increase,
because a similar thinning of ependyma and choroid plexus was
also observed in the 3rd ventricle (Fig. 4b, c) and in the 4th
ventricle (Supplementary Fig. 4a), which do not present with
enlargement, consistent with the fact that the 3rd and 4th
ventricles are downstream of the CSF circulation block.
To rule out that the atrophic “endothelial” cell morphology of
the ependymal layer and the decreased expression of S100β was
due to delamination/cell loss, we quantified the number of
ependymal cells in H&E-stained sections of the 4th ventricle (as
described under see “Methods” section, and exemplified in
Fig. 3b). Despite the wider variability (f-test, p= 0.0026) in cell
number per segment of ependyma analyzed, in trip6−/− brain,
there is no statistically significant difference in the mean
ependymal cell density between control and trip6−/− brain
(Fig. 3d). Thus, at least in the trip6−/− 4th ventricle, there was no
overall reduction in ependymal cells.
One of the essential functions of ependymal cells is the
formation of motile cilia. We quantified different aspects of
ependymal ciliation, in the 4th ventricle (Fig. 3, see “Methods”
section for detailed description and statistical analysis). The
aberrant ciliation of the ependyma, observed by histopathological
analysis, was confirmed by this quantification, in H&E-stained
brain sections (Fig. 3c), and by cilia-specific immunofluorescence
(Figs. 4 and 5 and Supplementary Movies 3 and 4).
First, the ciliation index (defined as the percentage of ciliated
ependymal cells per ventricular section analyzed) was found to be
significantly reduced—by 30%—in trip6−/− (Fig. 3e). Second, we
quantified cilia length. Briefly, ependyma segments of 10 μm in
length, along the ventricular wall, were examined for the presence
of cilia, and cilia length was subsequently measured (Fig. 3f). The
percentage of un-ciliated segments of ependyma (marked by * in
Fig. 3c) was very significantly increased (3.4 times) in trip6−/−
(Fig. 3h). Moreover, even in the ciliated segments, the cilia “lawn”
height (defined as an approximate measure of cilia length) was
significantly reduced (Fig. 3i), with median cilia length being
reduced by ca. 14% (Fig. 3i). Figure 3g summarized the cilia
height through all 10 μm segments (the data of 3h and 3i
combined). These results demonstrate that the ciliation index
likely underestimates the phenotype, which is better represented
by analysis of ciliation along ependyma segments (Fig. 3g), rather
than per ependymal cell (Fig. 3e).
Immunofluorescence microscopy with cilia-specific markers
confirmed the cilia defect in trip6−/− ventricles. Ependymal cell
layers labeled with antibodies against acetylated α-tubulin (Ac.TUB)
(cilia marker30) showed clusters of cilia at the trip6+/− ependyma
that were reduced or eliminated in trip6−/− (Fig. 4d, e; compare
trip6−/− in e with trip6+/− in d; and compare Supplementary Fig. 3b,
c with a). The ependymal phenotype was identical in the LVs of
hydrocephalic (Fig. 4e) and non-hydrocephalic (Fig. 4f) trip6−/−
mice, indicating that it was not caused by increased fluid pressure.

























































































44.03% 0.46% 0% 
p<0.0001
p<0.0001p=0.2972
Fig. 2 trip6 deletion causes perinatal hydrocephalus. a Macroscopic view
of cranial malformation indicative of hydrocephalus (arrow) in a trip6−/−
mouse (unaffected trip6+/− littermate shown for comparison). b
Quantification of hydrocephalus incidence in control and trip6−/− mice. n
number of mice assessed (p < 0.0001, two-tailed chi squared test; see also
Methods and Supplementary Table 5). Source data are provided as a
Source Data file. c H&E stained sagittal brain sections showing enlarged
LVs in a trip6−/− mouse (unaffected trip6+/− littermate shown for
comparison). d Coronal brain MRI images from control and hydrocephalic
mice at the level of lateral (LV) and 3rd ventricle (3V) demonstrate the
enlargement of LV, but not 3V, in the trip6−/− mouse. In the colorized heat
maps the fluid-filled ventricles appear yellow. e Lateral (“sagittal”) (L) and
horizontal (H) brain MRI sections and lateral view of a maximum intensity
projection (MIP) reconstruction depicting the ventricular system (white) in
mice of the indicated genotypes (P21). Dashed lines (L and H) indicate the
section planes of lateral and horizontal views, respectively. The LV is seen
only in L40 and not in L36 in the wt. In control, LV, vs. 3V and the 4th
ventricle (4V) can only be visualized in separate lateral sections (L40, L36)
while the LV of trip6−/− encompasses several sections (L31, L35). In
contrast to LV, the 3V and 4V are not enlarged. The MIP views show the
entire ventricular system. Note the massive expansion of the ventricular
system in trip6−/− compared to the heterozygote. Scale bar: 1 mm (c, d).
For 3D reconstruction of the complete set of sections, please see
Supplementary Movies 1 and 2.
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(clusterin-associated protein1; CLUAP1/IFT38) revealed, similarly,
the diminished cilia length (Fig. 4g, h).
To improve spatial resolution of subcellular structures, including
the cilia, Z-stacked optical sections of immunofluorescence micro-
scopy images were deconvolved and 3D reconstructed (Fig. 5 and
Supplementary Movies 3, 4). Regions of the trip6−/− LV confirmed
the greatly reduced cilia formation or cilia elongation defects (arrows,
Fig. 5b, c). Nevertheless, in agreement with the quantification data
(Fig. 3) ependyma regions with apparently normal cilia were also
observed (arrowheads; Fig. 5, compare a with b; Supplementary
Movies 3 and 4). Reduction in S100β intensity correlates with
aberrant/absent ciliation (Supplementary Fig. 4a, b) suggestive of a
link between S100β acquisition and cilia formation.
Notably, the formation and subcellular localization of basal
bodies appeared unaffected by trip6 deletion (Fig. 5e, f compare to
5d; Supplementary Movie 5). Taken together these data suggest
that cilia elongation, rather than nucleation, is compromised by
the trip6 deletion.
Deletion of trip6 also affected the choroid plexus, both in size
(Supplementary Fig. 1d) and in ciliation (Fig. 4b, c). As ependymal
and choroid plexus cilia differ both in developmental fate and in
function (see “Discussion” section), this observation suggests that
absence of TRIP6 affects cilia more generally.
Trip6 deletion does not affect adherens junctions. In control
brain, TRIP6 co-localized with β-catenin and N-cadherin (Figs. 1b
and 6 and Supplementary Fig. 1c, d) as well as with ZO1
(Fig. 1c). This was to be expected given the role of TRIP6 in the
assembly of adhesion complexes in cell culture8,9,13. The role of
adhesion complexes in ciliogenesis is well documented31. Thus,
in view of the ciliary malformation of choroid plexus and
ependymal cells in trip6−/− mice, we asked whether the adhe-
sions were affected. Surprisingly, localization of β-catenin and
ZO1 at cellular membranes was not altered in trip6−/− mice
(Figs. 5 and 6 and Supplementary Fig. 1d, Supplementary
Movies 3, 4) indicating that cell-to-cell adhesions and tight
junctions do not—at least not structurally—depend on TRIP6.
Despite maintenance of β-catenin labeled cellular adhesions

































































































































































































Fig. 3 Histological characterization and quantification of periventricular ependymal cells and their cilia. a Representative images of H&E stained
ependyma, comprising ependymal cells (Epn) and interspersed basal cells (arrowheads), lining the 4th ventricle (Vent) in trip6+/− (Control) and trip6−/−
mice. Note the poorly differentiated epithelial layer comprising atrophic ependymal cells that exhibit “endothelial” (flattened) cell morphology and aberrant
ciliation, as well as the relative sparsity of basal cells in the trip6−/− brain. b Semi-schematic depiction of the segmentation method used in cell number and
ciliation index quantification of the ependyma. Individual ependymal cells were determined by their nuclei (circles) and inspected for the presence of cilia
on their apical site (lines). c Representative images depicting native, mild and severe phenotypes for cell number and ciliation of control and trip6−/− mice.
Quantification demonstrated that although the mean number of ependymal cells was not altered (d), ciliation is significantly affected (e). [The box plot (e)
indicates the median (middle line), the interquartile range from 1st to the 3rd quartile (box) and the range of the minima to maxima (whiskers)]. f Semi-
schematic depiction of the method used for quantification of cilia length and coverage of the ependyma. Individual segments of 10 µm were determined
(horizontal full and dotted lines) and maximum cilia “lawn” height was measured at each second segment (vertical lines) for quantification and found to be
reduced in trip6−/− mice (g). The coverage of cilia (indicated as the fraction of unciliated segments per 100 µm) is significantly reduced in trip6−/− mice
(h). The length of cilia (determined as maximum cilia “lawn” height per 10 µm ciliated segment) was also significantly reduced (i). Further information on
quantification methodology and statistical tests performed can be found in “Methods” section (including Supplementary Table 7). The statistical
significance of the analyses is represented by the p-values indicated in the graphs (e, d, g, b, h, i). Source data are provided as a Source Data file. Chp
choroid plexus. Asterisk (*) indicates unciliated areas. Scale bars: 10 µm.
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trip6−/− ependymal cells, cilia failed to elongate (Fig. 6, several
areas are selected and magnified for better visualization).
TRIP6 is associated with ciliary structures. So far we have
documented that ependymal and choroid plexus are malformed
in the absence of TRIP6 and that they lack the normal abundance
of cilia. At which level does TRIP6 act?
The decisive observation was obtained by co-immunofluorescence
microscopy: ARL13B (the cilium component ADP ribosylation factor
like GTPase 13B32,33; Fig. 7a), CLUAP1 (Fig. 7b) and TRIP6 co-






















































































Fig. 4 Defective differentiation of ependyma and choroid plexus in trip6−/− mice. Schematic illustration of mouse brain ventricles and choroid plexus,
with vertical lines indicating the approximate coronal section planes analyzed (a). Scheme (b′) and immunofluorescence microscopy analysis (b) of
ependyma (Epn) and choroid plexus (Chp) within the 3rd ventricle (Vent: ventricular lumen) in control brain sections, illustrating ciliation and ependymal
cell differentiation [visualized by acetylated tubulin (Ac.TUB) and S100β labeling, correspondingly]. Nuclear DNA is stained by DAPI. Note that S100β is
expressed in ependymal (arrows, b–f) but also in non-ependymal cells (arrowheads, b–f). Trip6 deletion (c) results in differentiation defects indicated by
reduction in ciliation and S100β expression. Importantly, these defects [which are apparent also in the LV (Vent) (e, f cf. control d)] are observed in mice
with (e) or without (f) hydrocephalus, suggesting that differentiation defects precede development of this pathology. For higher magnification images,
please see Supplementary Fig. 3. Defective ciliation in trip6−/− brain is further demonstrated by labeling the ciliary transport protein CLUAP1 (h). Yellow
arrows indicate the height of the cilia lawn in control (g) and trip6−/− (h) specimens. Scale bars: 50 μm (b–f), 10 μm (g, h).
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b). These data suggest that TRIP6 is part of the ciliary structure. A
more detailed localization of TRIP6 was obtained by super resolution
microscopy. TRIP6 ‘puncta’ were detected at the base, along the
length and at the tip of the cilium of LV ependymal cells (Fig. 7c, d).
The distribution of TRIP6 staining differed among cilia, possibly
capturing different subciliary locations of TRIP6 in the process of
intraflagellar transport. In the absence of TRIP6, Ac.TUB foci
accumulated along the ventricular surface without proper cilia
formation (Fig. 7e, compare to 7d; see also Supplementary Movie 4)
suggesting that the ciliary axoneme failed to elongate.
Requirement for TRIP6 in ciliogenesis. To further investigate
the putative roles of TRIP6 in ciliogenesis, we used the murine
choroid plexus cell line Z31034. In monolayer culture, these cells
formed adherens junctions (Supplementary Fig. 5a) colocalizing
β-catenin and TRIP6, similarly to choroid plexus epithelial cells
in vivo (Fig. 1c). In agreement with published reports9, TRIP6
also localized at focal adhesions as illustrated by anti-paxillin
immunofluorescence staining (Supplementary Fig. 5b, d).
Upon serum starvation, Z310 cells developed primary cilia. In
the cells treated with siControl, TRIP6 localized at the axoneme,









































Fig. 5 Defective ciliation of ependyma in trip6−/− mice. Deconvolved immunofluorescence microscopy images of the ependyma of three trip6−/− and
two control trip6+/− mice (all at P4) depict, in high spatial resolution, adhesions (labeled by an anti-β-catenin antibody), cilia (anti-acetylated α-tubulin
labeling), and basal bodies (anti-γ-tubulin labeling). An animated 3-D reconstruction of the images is presented in Supplementary Movies 3, 4, and 5.
There are no obvious adhesion defects in the ependyma, neither in the LV (a cf. b, c, f) nor in the 3rd ventricle (d cf. e), as demonstrated by comparison of
control (a, d) with trip6−/− (b, c, e, f) specimens (β-CATENIN). In contrast, in the LV, defective ciliogenesis in trip6−/− mice of mild (b) or severe (c)
phenotype (degree of cilia absence) is demonstrated by ependyma areas presenting with a thin layer of acetylated α-tubulin labeling (Ac.TUB, arrows). For
comparison, normal cilia bundles are indicated by arrowheads, in control (a) and trip6−/− (b, c) specimens. (see also Fig. 7d cf. e, for higher resolution
images of cilia). Regular formation and ventricular localization of basal bodies, in trip6−/− ependymal cells (e, f) of 3rd and LVs, is visualized by the
punctate γ-tubulin staining pattern. The brackets indicate clusters of basal bodies within single ependymal cells (γ-TUB; d–f). Scale bars: 10 μm.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-26057-6 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:5887 | https://doi.org/10.1038/s41467-021-26057-6 | www.nature.com/naturecommunications 7
best seen in the magnification of two individual cilia (Fig. 8a’). Is
TRIP6 required for the formation of primary cilia in vitro?
Treatment of Z310 cells with trip6 siRNA (siTrip6) resulted in
reduced number (Fig. 8a–c) and length (Fig. 8d) of ciliary
structures compared to cells transfected with non-targeting
siRNA (siControl). Most cells transfected with siTrip6 produced,
in lieu of a primary cilium, only a single “punctum” comprising
basal body (labeled with anti-γ-tubulin (γTUB)) and a very short
axoneme (marked by ARL13B). The increased number of puncta
in cells with downregulated trip6 suggests that cilia initiation is
reduced or delayed in the absence of TRIP6.
To better understand how is ciliogenesis compromised, we
analyzed the localization of several ciliary components at 24 h
post cilium induction. While puncta in the control culture carried
acTUB, γTUB, IFT88, CLUAP in addition to ARL13B, as
expected from an initiating cilium, the puncta observed in
siTrip6 treated cultures differed from those in the control: Several
ARL13B and γTUB positive puncta lacked acTUB, IFT88, or
CLUAP (Supplementary Fig. 6b). Moreover, γTUB staining was
often reduced. These conditions resemble an arrest very early in
cilia initiation35, also compatible with the reported colocalization
of TRIP6 with centriolar appendices36. Other puncta presented
with excessive accumulation of acTUB or CLUAP around the
basal body (Supplementary Fig. 6c). Finally, abnormal cilia with
proximal or distal accumulation of ciliary components were
observed (Supplementary Fig. 6d). Similar arrest phenotypes have
been reported upon deletion of individual intraflagellar transport
(IFT) components37.
Quantification confirmed that siTrip6 significantly reduced the
number of cells carrying cilia (Fig. 8b). The fraction of cells with
properly formed cilia was diminished (Fig. 8c) and—in those cells
that formed cilia—the cilium length was very significantly
reduced (Fig. 8d). Thus, in addition to its role in motile cilia
formation, TRIP6 is obviously required for primary cilium
formation and elongation.
In contrast to ciliogenesis, downregulation of trip6 in Z310
cells by siRNA did not abolish either adherens junctions or focal
adhesions (Supplementary Fig. 5d, e), as had been observed in
other cell types (Figure EV4 in ref. 13). At focal adhesions,
residual TRIP6 was still visible indicating a longer protein half-
life. Most likely, TRIP6 is stabilized when incorporated into focal
adhesions, remaining present longer than at adherens junctions.
Thus, in cultured cells as in the brain, downregulation of TRIP6
did not affect adhesion complexes (compare with Figs. 5 and 6).
TRIP6 carries three C-terminal LIM domains with different
interaction specificities. Moreover, the N-terminal half harbors
additional motifs for binding proteins. The ability to act as an
assembly platform is further increased by two dimerization
domains38. To examine whether dimerization was required for
the ciliogenetic role of TRIP6, we blocked the former by
overexpressing a peptide competing with the dimerization
domains in Z310 cells. The resulting phenotype was similar to
that obtained after downregulation of trip6 expression by siRNA:
the number and length of the cilia were significantly reduced
upon transfection with the blocking peptide as compared to






















































































Fig. 6 Trip6 deletion affects ciliogenesis but not cell-cell adhesion. Immunofluorescence microscopy-based expression and localization analysis of cilia
(CLUAP1) and cell-cell adhesion (β-CATENIN) markers, as well as of TRIP6, in the LV of control (trip6+/−) and trip6−/− mouse brain. Their comparison
demonstrates TRIP6 deletion and ciliation defects in trip6−/− specimens, but no obvious adhesion defects. Magnification panels depict selected areas
(indicated by white frames in the low magnification images), re-oriented with the ventricular lumen positioned at the lower part of each image. Epn
ependyma, Chp choroid plexus. Scale bar: 50 μm.
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Additionally, the block of dimerization caused “puncta” appear-
ance of severely reduced cilia length (Fig. 8h). These data suggest
that TRIP6 requires the full complement of protein binding
options, and that it may serve as an assembly factor for
multiprotein complexes involved in cilium formation. Hence, in
addition to its role in motile cilia formation, TRIP6 is obviously
required for primary cilium formation and elongation.
Together, the in vitro phenotypes resulting from TRIP6
disruption corroborate our in vivo observation from trip6−/−
mice. Deletion, downregulation or inhibition of dimerization of
TRIP6 leads to reduction in the percentage of ciliated cells. Even
when cilia are formed, they are shorter (Figs. 3 and 9). Ciliary
components are nevertheless still recruited to the ventricular
surface of the ependymal cells in vivo (Figs. 5a, b, 6, and 7d), also
indicated by the “puncta” morphology in the cultured choroid
plexus epithelial cells (Fig. 8).
Additionally, similarly to the brain cilia phenotype (Fig. 7c),
super resolution microscopy of the cilia of Z310 cells (Fig. 9)
revealed a punctate distribution of TRIP6 along the length of the
ciliary axoneme, somewhat differing in distribution between
individual cilia (arrows in Fig. 9b, that depicts representative
examples of TRIP6 localization from 28 cilia analyzed). This is
suggestive of “snapshots” illustrating different stages of intra-
flagellar transport. In contrast, the structural cilia components
Ac.TUB and ARL13B, were more uniformly distributed along
cilia. TRIP6 also co-localized with γ-tubulin at the basal
bodies (Fig. 9b; basal bodies indicated by circles). Compared to
TRIP6, CLUAP1 was predominantly located at the distal and
proximal ends of the cilia (Fig. 9c), in agreement with previous
reports39.
The siTrip6 induced “puncta”, shown in Fig. 8, represent in fact
short cilia as revealed by super resolution microscopy (Fig. 9e; a
total of 20 siControl and 15 siTrip6 cilia were imaged, a selection
is presented). Pericentrin (PCNT, a component of the pericen-
triolar material surrounding the basal bodies) localization was not
affected. Due to partial downregulation of trip6, cells with full-
length cilia were detected in the same culture (Fig. 9f). They
expressed TRIP6 and localized it along the axoneme and at the
basal body (Fig. 9f) similarly to cells transfected with the control
siRNA (Fig. 9d).
Discussion
We report that the LIM domain protein TRIP6 promotes the
differentiation of ependyma in the developing mouse brain.
Notably, we have uncovered a role for TRIP6 in brain ciliogenesis.
In humans, ciliogenesis deficiencies cause numerous diseases—
ciliopathies—which affect many organs including the brain25,40.
The ciliopathy-like phenotype in the brain of trip6 knockout
mice, which includes the formation of a hydrocephalus, led us to
the discovery of a role for TRIP6 in the formation of ependymal
cilia. In the absence of TRIP6 fewer and shorter cilia are formed,
with a fraction of ependymal cells carrying the basal bodies
without extended axoneme.
TRIP6 is a member of an assembly factor family of LIM
domain proteins. Given their overlapping molecular properties
and structural similarities, it is plausible to hypothesize that other
members of the family could also function in ciliogenesis. This
seems to be the case: in the Xenopus embryo the knockdown of
WTIP altered the location of basal bodies and reduced cilium
length41. ZYXIN, LPP as well as TRIP6 were detected in the
ciliary membrane-associated proteome of inner medullary col-
lecting duct cells42. In the brain, however, TRIP6 is the sole
member of the LIM domain family expressed during the gen-
eration and maturation of the ependymal cells and differentiation
of choroid plexus (between E14.5 and birth, Fig. 1, and mouse
Ac.TUB / TRIP6 / DAPI
b
ARL13B TRIP6 ARL13B / TRIP6 / DAPI
























Fig. 7 Localization of TRIP6 in motile cilia of brain ependyma, via super
resolution microscopy. Co-localization of TRIP6 with the cilia markers
ARL13B (a) and CLUAP1 (b) in cilia of control mice ependyma, via
double-labeling immunofluorescence microscopy (Arrowhead indicates
localization of ARL13B also at the ventricular membrane, see Results).
Super resolution microscopy (c–e) further demonstrates the co-
localization of TRIP6 with acetylated α-tubulin (Ac.TUB) within individual
cilia (c). In controls (c, d), note the punctate labeling of TRIP6 (arrows)
revealed by super resolution microscopy, in contrast to the more uniform
Ac.TUB labeling pattern along the axoneme (c, d). In trip6−/− ependyma
(e), Ac. TUB has accumulated along the ventricular cell surface but the
axoneme failed to elongate. Scale bars: 5 μm (a), 10 μm (b), 1 μm (c),
2 μm (d, e).
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genome informatics atlas, ref. 21). Hence, it is not substituted by
other family members. Although mice with gene disruptions of
individual members of the ZYXIN family are viable and showed
no severe phenotype, including no hydrocephalus16–20, an ana-
lysis of ciliogenesis in these mice has not yet been published.
Therefore it remains to be shown whether LIM domain proteins
function redundantly in ciliogenesis.
The brain ciliopathy in trip6−/− mice resembles those phe-
notypes generated by a large variety of gene mutations or altered
expression of genes which ultimately affect ciliogenesis (a com-
prehensive list can be found in ref. 25). Most frequently the
axoneme length is affected43. To cite a few examples: a splice
donor site mutation in the gene for axonemal protein coiled-coil
domain 39 was found to be the cause of the progressive hydro-
cephalus (prh) mouse phenotype44. The length of motile cilia,
reduced in prh mice, is apparently critical for function. Disrup-
tion of the gene encoding the ciliary component ARL13B also
results in shortened cilia32,45. Interestingly, ARL13B acts at two
different subcellular locations exerting two functions which can
be distinguished by mutation of the cilia targeting sequence: cilia
length regulation requires ARL13B ciliary localization while Wnt
signaling control is mediated by ARL13B from “outside the
cilia”33. As a last example, both inhibition of or enhanced actin
polymerization affect cilia disassembly or formation46–48.
The defects in differentiation and ciliogenesis in the developing
brain of the trip6−/− mice are associated with severe hydro-
cephalus. However, hydrocephalus was observed in only 44% of
the knockout animals, whereas the impaired ciliogenesis of
ependymal cells was fully penetrant. Also ciliation of the choroid
plexus appeared to be affected. These observations clearly suggest
that hydrocephalus is not a direct consequence of the loss of
TRIP6, but rather a secondary effect. Furthermore, the enlarge-
ment was restricted to the LVs, suggesting an occlusion of CSF
passage downstream of these ventricles. This phenotype strikingly
resembles human genetically determined non-communicating
(obstructive) hydrocephalus, a condition caused by occlusion of
CSF passage, which represents the most frequent hydrocephalus
etiology besides CSF overproduction25. Thus, it seems that the
obstructive hydrocephalus observed upon deletion of TRIP6 is
caused by a CSF circulation block in the foramen of Monro
(upstream of the 3rd ventricle) and/or in the aqueduct of Sylvius,
between the 3rd and 4th ventricle.
Given the reported role of TRIP6, based on in vitro experiments,
in both focal adhesions and adherens junctions8,9, one would
hypothesize that loss of TRIP6 promoted detachment of ependymal
cells, ultimately occluding the aqueduct. Such a mechanism has
indeed been reported in cases of congenital hydrocephalus26,27,49,50
as well as in animal models of defective cell adhesion51–53. In the
trip6−/− mouse, the ependymal epithelium indeed exhibits poor
differentiation presenting with atrophic cells of endothelial mor-
phology and reduced expression of S100β (Fig. 3 and Supplementary
Fig. 4) that may delaminate and, in the narrow CSF canals, cause
blocks by adhering to the opposite wall. However, the deletion of
trip6 did not seem to affect formation of adherens and tight junc-
tions, whilst the number of ependymal cells was not, at least in the
4th ventricle, significantly reduced. Whether cell–cell adhesion
strength is reduced by the defective differentiation and results in
clotting at critical sites, remains a hypothesis.
Adhesion complexes exert regulatory functions through actin
dynamics8,9. Notably, adhesion complexes such as those localized
at focal adhesions are also found in basal bodies, thus linking cilia
with the actin cytoskeleton31. Actin polymerization indeed affects
primary cilium length and function43,54. Thus, a putative reg-
ulation of the function of TRIP6 in ciliogenesis exerted via the
actin cytoskeleton cannot be ruled out at this time. However, the
localization of TRIP6 in the axoneme, combined with the fact
that, in the trip6−/− mouse, basal body translocation to the
ventricular side of the ependymal cells was not compromised, do
not speak for an actin-mediated mechanism.
In addition to its function in ependymal cell cilia, TRIP6 is also
required for the formation of primary cilia. Furthermore, our own





































































































































































Fig. 8 Downregulation of trip6 by siRNA or blocking of TRIP6 dimerization, in the choroid plexus-derived cell line Z310, impairs cilium elongation or
ciliogenesis. Z310 cells, transfected with the indicated siRNAs (siTrip6 or siControl) (a) or peptides (dimerization blocking or control) (e), were serum-
starved to induce primary cilium formation (see “Methods” section for detailed description). The cells were analysed by immunofluorescence microscopy
to visualize basal bodies (labeled by anti-γ-tubulin antibody) and the primary cilium (anti-ARL13B), and were counterstained with anti-TRIP6 and DAPI (a’
shows magnified cilia from panel a). Both inhibitory treatments significantly impaired primary cilium formation (b, f; analysed by two-tailed Fisher’s exact
test) or—in those cells carrying cilia-like structures—cilium morphology (c, g; two-tailed Fisher’s exact test) and length (d, h; two-tailed Student’s t-test).
Both phenotypes were adversely and significantly affected. The box plots (d, h) indicate the median (middle line), the interquartile range (IQR) from 1st to
the 3rd quartile (box), and the upper edge (Q1+ 1.5*IQR) to lower edge (Q1− 1.5*IQR) (whiskers). In the morphological assessment, “puncta” indicate
basal bodies without associated axoneme. For detailed description of quantification and statistics, see “Methods” section. Source data are provided as a
Source Data file. Additional analysis of the RNAi experiments is presented in Supplementary Fig. 5. Scale bars: 10 μm (a, a', e).
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airway cilia, suggesting that the protein is required for ciliogenesis
in general. A role for TRIP6 in formation of the primary cilium
(our in vitro analysis), of the ependymal cell motile cilia, of the
airway motile cilia and of the choroid plexus cilia (our in vivo
analysis) suggest involvement of the protein in a process shared
by these distinct cilia types.
Primary and motile cilia differ in their structure and function











Fig. 9 Localization of TRIP6 in primary cilia of choroid plexus-derived Z310 cells, via super resolution microscopy. Representative examples of six
primary cilia, labeled with the structural cilia components acetylated α-tubulin (Ac.TUB), ARL13B or CLUAP, and with anti-TRIP6. TRIP6 localized in foci
along the axoneme, exhibiting variable distribution among individual cilia (arrows in b, f) when compared to the more uniform sub-ciliary localization of
Ac.TUB and ARL13B (a, b). Super resolution identifies two major axonemal sites of CLUAP (c). Additionally, TRIP6 partially co-localized with the basal body
markers pericentrin (PCNT; a, d) and γ-tubulin (γ-TUB; b). Basal bodies are indicated by circles. Downregulation of trip6 expression, by siRNA, reduced the
length of the axoneme without affecting the basal body (e cf. d). Nevertheless, those cells presenting with elongated cilia, in the siTrip6-treated cultures
(partial downregulation), were found to still express TRIP6 that localized along the axoneme (arrows, f) and in the basal body (circle, f). Scale bars: 1 μm.
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of axonemal microtubules, which is absent in primary cilia axo-
nemes (designated as a 9+ 0 structure) but present in motile
(9+ 2) cilia57. Terminally differentiated ependymal cells and
choroid plexus epithelial cells carry motile cilia, however at dif-
ferent stages of development. Ependymal cells differentiate from
radial glia, starting at E14.5, but full differentiation occurs only
after birth, when they become post-mitotic and form cilia with
directional motility44,55,58. Ependymal cilia promote CSF flow,
e.g., at the medial wall of the foramen of Monro44,59. Choroid
plexus formation starts earlier (at E11.5) with concomitant for-
mation of transiently motile cilia60, which become immotile after
birth61. Their specific motility role remains to be defined. Primary
cilia, in contrast, are immotile and serve as sensory organelles62.
In the brain, primary cilia mediate sonic hedgehog and Wnt
signaling (reviewed in ref. 63). Despite these differences between
cilia types, multiple structural studies have revealed morpholo-
gical similarities, and proteome analysis has identified compo-
nents in common36,64. TRIP6 is, apparently, such a component.
During development, radial glia cells give rise to the ependymal
cells as well as to less abundant basal cells, some of which are
stem cells, that are localized beneath and interspersed within the
single-layered epithelial cell layer of the ependyma28. In the
trip6−/− mouse, VZ basal cell numbers appear to be reduced.
Although speculative at this time, as the number and expression
profile of the basal cells remain to be characterized, this obser-
vation raises the hypothesis of an earlier developmental origin of
the trip6−/− phenotype. Whether the defects in ependyma and
basal cells can be traced back to their development, from
primary-cilia carrying radial glia, or to a defect of transcriptional
regulation, is a topic that warrants further investigation.
In addition to its ciliary function, TRIP6 also acts as tran-
scription regulator via a nuclear isoform38,65 and thus could
regulate differentiation programmes. The hypothesis that TRIP6-
dependent transcription regulates ependymal differentiation,
including ciliogenesis, remains to be tested. In support of this
hypothesis, postnatal neuronal progenitor cells, cultured in vitro,
suffered from poor proliferation upon TRIP6 knock down22.
Along similar lines, TRIP6 has been postulated to promote pro-
liferation in cancer (e.g., ref. 66; https://www.proteinatlas.org/
ENSG00000087077-TRIP6/pathology). However, gross examina-
tion of trip6−/− mouse embryos has not yet revealed any obvious
proliferation defects, nor have we detected, with available anti-
bodies, nuclear TRIP6 in brain cells. Nevertheless, in transcrip-
tion regulation minute protein levels may suffice for large effects.
Protein expression below the current detection level might still be
required for differentiation of the ependyma. Alternatively, loss of
cilia and of their regulatory role could be the primary event that
compromises transcriptionally dependent cell maturation. Thus,
TRIP6 could exert two functions, in the nucleus and as compo-
nent of ciliogenesis.
The super resolution microscopy data suggest a molecular
function of TRIP6 in the ciliary axoneme. As postulated above,
TRIP6 exerts a partially limiting supportive function, either
indirectly (via differentiation control) or directly (via a structural
role) in cilia formation. A shared feature of motile and primary
cilia, mediated by the same protein complexes in both organelles,
is the intraflagellar transport (IFT) into and out of the ciliary
axoneme67 (reviewed in ref. 68). Axonemal transport indeed
requires organizing factors and scaffold proteins69. Thus, dis-
rupting IFT would affect both motile and primary cilia, as we
observed upon trip6 deletion or downregulation. TRIP6 partially
co-localized with IFT components (CLUAP1/IFT38 and
ARL13B). These data are in agreement with the reported inter-
action of TRIP6 with CLUAP1 in cytoplasmic complexes of
cultured cells70, as well as with centrosomal and with cilium-
transition-zone proteins36 (http://prohits-web.lunenfeld.ca). The
increase in “puncta” in the absence of TRIP6 and the altered
localization of ciliary components in the resulting structures
suggests that ciliation under these conditions is aberrant. The
puncta phenotype resembles the ciliogenesis defects caused by
deletions of IFT components37,71. Finally, in addition to a role in
cilia initiation, the punctate localization of TRIP6 along the
axoneme, both in vivo and in vitro, is consistent with a function
in transport complexes.
Notably, our results demonstrate that TRIP6 function in
ciliogenesis requires homodimerization. Dimerization, which
doubles the protein interaction sites, most likely enables TRIP6 to
interact simultaneously with several cargo proteins—in addition
to components of the IFT machinery, CLUAP1/IFT38 and per-
haps ARL13B72. In support of this conclusion, TRIP6 was loca-
lized in the proximity of centriolar satellite and appendage
proteins, and within the centrioles themselves, along with pro-
teins of the primary cilium transition zone36 (http://prohits-
web.lunenfeld.ca). This wide distribution of interactors is a
characteristic of an adapter protein/assembly factor. Conversely,
our results show that TRIP6 is not required for the replication
and translocation of basal bodies in ependymal cells, indicating
that the regulatory stimuli inducing cilium formation are not
altered.
In conclusion, this study has unveiled a previously unrecog-
nized role for TRIP6 in ciliogenesis, which is critical for brain
development. Our findings expand the spectrum of functions of
this LIM domain protein beyond the regulation of adhesion,
migration, and proliferation. Most importantly, this work has
uncovered the essential role of a protein assembly factor in
mammalian ciliogenesis.
Methods
Generation of trip6 knockout mouse line, colony maintenance and genotyping.
Mice carrying trip6 deleted alleles were generated by ES cell gene targeting as
depicted in Supplementary Fig. 2. Briefly, E14.1 mouse embryonic stem (ES) cells
were electroporated with the linearized targeting construct, and correct targeting
events were identified by Southern-blot hybridization. Selected ES cell clones were
subsequently electroporated with the pMC-Cre expression plasmid for deletion of
the floxed neo-resistance cassette and generation of clones carrying floxed or
deleted alleles of trip6. Finally, blastocyst microinjection and transfer into foster
mice was employed to generate chimaeras and knockout mouse lines. The resulting
trip6 knockout mouse line was backcrossed to C57BL/6J mice for ten generations.
The trip6 knockout colony was maintained by breeding heterozygous animals.
To avoid genetic drift, routine backcrossing to the parental C57BL/6J strain was
employed. The genotype was determined by PCR on DNA extracted from tail
tissue using the primers trip6-28F, trip6-29R, and trip6-30R (Supplementary
Table 1).
Mouse experiments (including embryo isolation), colony maintenance and
breeding were conducted in accordance with Directive 2010/63/EU and the
regulations of the Thüringen Landesamt für Verbraucherschutz (Thüringen,
Germany) with protocols approved by the respective ethics committee
(Tierschutzkomission, Thuringian Animal Welfare Committee) and under the
oversight of the FLI Animal Welfare Committee. Animals were provided with
standard laboratory chow and tap water ad libitum, and kept at constant
temperature (21 °C), with relative air humidity of 55% ± 15 and constant light cycle
(12 h-light, 12 h-dark).
In situ hybridization. A cDNA fragment corresponding to nucleotides 995–1537
of mouse trip6 cDNA (RefSeq database, accession number NM_011639.373) was
generated by PCR and sub-cloned into the pGEM-T Easy Vector (Promega,
Madison, WI). Radiolabelled riboprobes were generated by using [35S]UTP
(Hartmann Analytik, Braunschweig, Germany) as substrate for the in vitro tran-
scription reaction. ISH was carried out according to ref. 74. ISH was performed on
brain sections of mice aged E14.5, E16, E18, P0, P3 and P6; shown are examples of
trip6+/+ (hybridization with antisense and sense probe) and trip6−/− (antisense
probe).
Briefly, frozen 20 µm thick frontal brain sections were fixed with 4% phosphate-
buffered paraformaldehyde solution (pH 7.4) at room temperature (RT) for 60 min
and rinsed with PBS (pH 7.4). Tissue sections were treated with 0.4% Triton-PBS
for 10 min (RT) and then incubated in 0.1 M triethanolamine (pH 8), containing
0.25% v/v acetic anhydride for 10 min. Following acetylation, sections were rinsed
several times with PBS, dehydrated by successive washings with increasing ethanol
concentrations, and air-dried.
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Radioactive 35S-labeled riboprobes were diluted in hybridization buffer (50%
formamide, 10% dextran sulfate, 0.6 M NaCl, 10 mM Tris/HCl pH 7.4, 1×
Denhardt’s solution, 100 mg/ml sonicated salmon-sperm DNA, 1 mM EDTA-di-
Na, and 10 mM dithiothreitol) to a final concentration of 25,000 cpm/µl. After
application of the hybridization mix, sections were cover-slipped and incubated in
a humid chamber at 58 °C for 16 h. Following hybridization, coverslips were
removed and transferred into 2× standard saline citrate (SSC; 0.3 M NaCl, 0.03 M
sodium citrate, pH 7.0). The sections were then treated with RNase A (20 mg/ml)
and RNase T1 (1 U/ml) at 37 °C for 30 min. Successive washes followed at RT in
1×, 0.5×, and 0.2× SSC for 20 min each and in 0.2× SSC at 60 °C for 1 h.
The tissue was dehydrated and, for microscopic analysis, sections were dipped in
KodakNTB nuclear emulsion (Kodak, Rochester, NY) and stored at 4 °C for 32 days.
Autoradiograms were developed in Kodak D19 for 5min, fixed in Rapid Fix (Kodak)
for 10min and analyzed under dark-field illumination. Experiments carried out using
the respective sense probe did not produce any hybridization signals.
Reverse transcription-quantitative PCR (RT-qPCR). Total RNA was isolated
from choroid plexus (4th ventricle) of wild type and trip6 knockout littermates at
P0 using TRIzol Reagent (Ambion, Life Technologies, Cat.# 15596026). Fifty
nanogram of total RNA was reverse-transcribed with the iScript cDNA Synthesis
Kit (Bio-Rad, Cat.# 1708891) and the cDNA was subjected to qPCR using iQ SYBR
Green Supermix (Bio-Rad, Cat.# 1708882) in a thermal cycler (Bio-Rad C1000
Touch Thermal Cycler - CFX384 Real-Time System). The gene-specific primers
Trip6-F, Trip6-R, Gapdh-F, and Gapdh-R (Supplementary Table 1) were used. The
trip6 primers are derived from the region of the gene that has been deleted in the
trip6 knockout mice (see Supplementary Fig. 2a). The qPCR results were analysed
using the Bio-Rad CFX Manager 3.1 software in the normalized expression (ddCt)
mode, with the single threshold Cq determination and baseline subtracted curve fit
settings. Gapdh (Gene ID: 14433) was used as the reference gene.
Western blot analysis. Tissues samples were dissected from wild type and trip6
knockout mice, frozen in liquid nitrogen, homogenized (in a Precellys 24 Homo-
genizer, Peqlab) in 1× RIPA lysis buffer supplemented with 1 mM phe-
nylmethylsulfonyl fluoride (PMSF) and 1 mM sodium fluoride (NaF), centrifuged
(10 min at 14,000 × g, 4 °C), fractionated by SDS-PAGE and subjected to western
blotting. Lysates from cell cultures were prepared according to ref. 75, after RNAi
(see below). TRIP6 protein was detected using the anti-TRIP6 A15 antibody
(Supplementary Table 3) and an HRP-conjugated secondary antibody (Supple-
mentary Table 4). Unprocessed scans of the uncropped western blots have been
included in the Supplementary Information.
Magnetic resonance imaging (MRI). To image ventricle size and morphology in
early post-natal mice in situ, a high resolution (150 μm isotropic) MRI protocol was
applied. Scans were performed on a clinical 3T scanner (Magnetom Trio, Siemens
Healthcare), using a dedicated mouse head coil. A Siemens SPACE sequence with a
constant flip angle was employed to acquire images with a resolution of 0.2 mm ×
0.2 mm × 0.16 mm using the following parameters: echo time TE= 125 ms,
repetition time TR= 1900ms, bandwidth = 130 Hz/px, Turbo Factor TF= 65 and
integrated fat saturation. MRI data were processed using the software syngo fast-
View (Siemens Healthcare). For depiction of multicolored axial images, multi-
planar reconstructions from the original 3D MRI data set were assembled.
Histological processing. Paraffin embedding of mouse brain was performed post
fixation in 4% phosphate-buffered paraformaldehyde solution (pH 7.4), at 4 °C, for
48 h. For sagittal sectioning, the brain was cut into two halves along the midline
before embedding; for coronal sectioning intact brain was embedded. Haematox-
ylin & Eosin (H&E) staining was performed according to standard protocol on
5 μm-thick brain sections, prepared from the paraffin-embedded tissue. Images
were acquired at an Olympus microscope (VS110 Virtual Slide Scanning System;
Olympus; Hamburg, Germany) with a 20× objective.
Cell culture, ciliogenesis induction, and transfection. The immortalized murine
(rat-derived) choroid plexus cell line Z310 (RRID: CVCL_F753) was kindly pro-
vided by W. Zheng, Purdue University. Z310 cells were cultured in DMEM high
glucose (4.5 g/l) supplemented with 10% FBS and 2mM glutamine at 37 °C, in 5%
CO2. The cell line had been characterized by genotyping, morphology, growth
assays and expression of the choroidal epithelium-specific marker TTR34. Cilio-
genesis was induced by starvation [DMEM low glucose (1 g/l), 0% FBS] at 37 °C, in
5% CO2, for 24 h.
RNAi experiments were performed using a pool of two ON-TARGETplus
siRNAs targeting the human trip6 open reading frame (Dharmacon). A pool of
four non-targeting siRNAs was used as negative control. The siRNA sequences are
listed in Supplementary Table 2.
Plasmid transfection was performed with Lipofectamine2000 (Thermo Fisher)
according to the manufacturer’s protocol. The pcDNA3.1 constructs encoding the
dimerization inhibitory peptide (amino acid 253–265 of human TRIP6, which is
conserved between mouse and rat) and the scrambled control peptide tagged with
mCherry have been previously described38. Z310 cells were transfected with the
relevant constructs and, from 48 h of post-transfection, they were starved for 24 h
to induce ciliogenesis. At 72 h of post-transfection, the cells were fixed in 3%
paraformaldehyde, permeabilized with ice-cold methanol and processed for
immunofluorescence labeling75.
Immunofluorescence microscopy. Immunofluorescence labeling was performed
on 5 μm-thick paraffin-embedded brain sections from E15.5 mice (trip6+/− n= 4),
P0 (trip6+/− n= 2; trip6−/− n= 3) and P4 mice (trip6+/+ n= 1; trip6+/− n= 5;
trip6−/− n= 6) according to Li et al. 2015 with the following modification: Heat
induced antigen retrieval was performed in citrate buffer (10 mM, pH 6.0) in a
decloacking chamber (Biocare Medical) by preheating at 95 °C for 10 min followed
by 125 °C for 25 min. Antibodies are listed in Supplementary Tables 3 and 4.
Microscopy and image acquisition (Z-stacks) was performed on an Axio Imager
microscope (Carl Zeiss Microscopy) equipped with Apotome slider and a 12-bit
grayscale cooled CCD AxioCamMRm camera, using a 20× or a 63 × 1.4 NA
objective. Representative images were selected from maximum intensity projections
(ZEN software, Carl Zeiss Microscopy), brought to a resolution of 300 dpi using
Photoshop (Adobe) and the area of interest was cropped. For selected images
(Fig. 5) deconvolution was performed (ZEN software, Carl Zeiss Microscopy).
3D reconstruction of the maximum intensity projections was prepared from
deconvolved images (Imaris image analysis software, Oxford Instruments). The
resulting images are presented as movies (Supplementary Movies 3, 4, and 5). To
enable visualization of adhesions in the atrophic area of the trip6−/− ependyma
(Supplementary Movie 4), in the β-catenin channel, the intensity histogram was set
at 500–11,000 (versus 4400–11,000, for Supplementary Movie 4). Intensity
histograms for other channels were set identically, in Supplementary Movies 3 and 4.
Super-resolution microscopy. Super-resolution imaging was performed on a
Leica TCS SP8 X-White Light Laser confocal microscope equipped with an
inverted microscope (DMI 8, Leica), a 100× objective (HC PL APO CS2 100 × 1.4
oil), Hybrid detectors and HyVolution-II software. Images were acquired as sug-
gested by the HyVolution module within the LAS microscope software (Leica).
Pre-settings in the HyVolution mode were established to achieve the highest
possible optical resolution. The super-resolved confocal stacks were deconvolved in
Scientific Volume Imaging (SVI)/Huygens deconvolution professional suite soft-
ware with GPU acceleration.
HyVolution is based on a combination of confocal imaging using sub-Airy
pinhole sizes (0.45–0.6 Airy Units, depending on the fluorophores used) with
subsequent computational image deconvolution76,77. With HyVolution, a lateral
resolution of 140 nm can be achieved, which is approximately 1.6 times higher than
the resolution achievable with conventional confocal microscopy.
The samples were mounted in ProLong Gold antifade mountant (Thermo
Fisher). HyVolution images were acquired using the 488, 546, and 647 nm laser
lines of the white-light laser to excite Alexa Fluor 488, Alexa Fluor 546 and Alexa
Fluor 647 dyes, respectively. Fluorescence emission was recorded on a hybrid
detector at 503–547 nm, 558–604 nm, and 654–719 nm, respectively, employing
sequential scan imaging to avoid bleed-through and/or cross-talk between spectral
channels. DAPI was excited using a 405 nm laser and detected using a PMT-
detector (430–502 nm). Brain sections from P4 mice (trip6−/+ n= 2; trip6−/−
n= 1) and RNAi-treated Z310 cells (28 cilia from untransfected control group; 20
cilia from siControl group; 15 cilia from siTrip6 group) were imaged.
Phenotype quantification and statistical analysis. Hydrocephalus incidence,
ciliogenesis, and ependymal cell density in vivo, plus ciliogenesis in vitro (in the
choroid plexus cell line Z310) were quantified and statistically analysed as
described in the sections that follow below. Statistical testing was performed using
GraphPad Prism 8 (GraphPad Software, Inc.).
Hydrocephalus incidence. Hydrocephalus was scored by macroscopic observation
of cranial malformations, the incidence was quantified in age-matched cohorts
(Supplementary Table 5) and its statistical significance was determined by pairwise
chi-squared test (two-tailed) between the genotypes, with Bonferoni correction
(n= 3 tests, at a p < 0.05 level, i.e., Padjusted < 0.017). The trip6−/− genotype
showed a significant influence on the incidence of hydrocephalus versus both
controls (trip6−/− vs. trip6+/−: p < 0.0001; trip6−/− vs. trip6+/+: p < 0.0001);
whereas the incidence in the heterozygous (trip6+/−) vs. the wild type (trip6+/+)
showed no significant difference (p= 0.2972).
Ciliogenesis quantification in tissue sections. The analyses were performed
using images of H&E stained sagittal brain sections of four control and five trip6−/−
mice (Supplementary Table 6).
For quantification of ependymal cell number and ciliation index, ependymal
cells lining the walls of the 4th ventricle were identified by nuclear staining
(haematoxylin). Cells were counted for each ventricular wall separately and the
length of each wall was measured using the software QuPath (V 0-2-0-m9)78.
To determine the distribution of ependymal cells, the cell number was
normalized to the length of the segment analysed. The data were tested for
normality of distribution and for the difference in variability of ependymal cell
numbers between the genotypes (f-test, p= 0.0026). The log-transformed values
were subsequently analysed by two-tailed Welch’s t-test (p= 0.2713).
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The ciliation index was defined as the percentage of ciliated ependymal cells per
ventricular section analysed (Supplementary Table 7). The ciliation indices were
not normally distributed (by Shapiro–Wilk and B’Agostino-Pearson normality
tests). The two-tailed Mann–Whitney test was therefore used to analyse the
difference in the median between the genotypes (p < 0.0001).
For quantification of the unciliated ependyma segments and of cilia “lawn”
height, ciliated, and unciliated areas along the 4th ventricle were analysed. First,
continuous regions of interest (ROIs) of 10 µm in length along the ventricular walls
were selected. For every second ROI, the height of the cilia lawn was measured at
the highest extent of cilia within this ROI. Finally, the ROIs that had a cilia lawn
height of 0 μm were counted as unciliated ROIs, normalized to the total number of
ROIs in the analysed ventricular section, and presented as unciliated fraction of all
measured ROIs per section. Differences between control and trip6−/− mice were
analysed by two-tailed Welch’s t-test (p < 0.0001).
For quantification of maximum cilia “lawn” height per 10 µm ROI, only ciliated
ROIs were considered. The two-tailed Mann–Whitney test was used to analyse the
difference in the median between genotypes (p < 0.0001).
Ciliogenesis quantification in Z310 cultured cells. Microscopy and image
acquisition were performed as described above using a 63 × 1.4 NA objective. The
cilia were imaged as Z-stacks encompassing the Z-positions from the basal body to
the distal tip of the axoneme.
Image based quantification of number of Z310 cells carrying cilia was
performed on Maximum Intensity Projections (MIP) for each image, using the
ZEN software (Carl Zeiss Microscopy). The “Grid” and “Events” functions from
the ZEN (desk) were used to facilitate the counting of the total number of nuclei
and the number of cilia in each field. A cilium was counted only when the basal
body (visualized by anti-γ-tubulin labeling) and the distal tip of the axoneme
(ARL13B) were visible. The cell objects that were not entirely located within the
field of view were only counted if carrying a cilium.
In vitro ciliogenesis was quantified in three replicate experiments
(Supplementary Table 8). Cilia length was measured using the “spline curve”
measurement tool of the ZEN software.
The statistical significance of the difference in the number of cells with primary
cilium and in the effect on cilia morphology of siControl vs. siTrip6 (p < 0.0001)
and of Control Peptide vs. Blocking Peptide (p < 0.0001) treatments was tested by
Fisher’s exact test. Cilia length datasets were tested for normality and subsequently
analysed by the two tail Student’s t-test, for differences in cilia length of siControl
vs. siTrip6 and of Control Peptide vs. Blocking Peptide (p < 0.0001) treatments.
Statistics and reproducibility. Micrographs depict representative examples from
experiments that analyzed age-matched cohorts of minimum three animals and
from in vitro experiments that had been independently repeated at least three
times. For detailed information on replicates, sampling and statistical testing, please
refer to the relevant Methods section and Supplementary Tables. The exact p values
are shown in the figure panels.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Source data accompanied this Article. Mouse trip6 cDNA is available at RefSeq
(NM_011639.3). The remaining data are available within the Article and Supplementary
Information. Source data are provided with this paper.
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